Stocks
Dr. Reddy's Laboratories (RDY) EBITDA margin US GAAP (year values) |
|||||||||
| 2023 | 2024 | 2024 | 2025 | 2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 30.3% | 29.0% | 31.7% | 29.7% | 20.0% | 22.1% | ||
| Changes by years, y/y, % | -14pp | -1pp | +3pp | -2pp | -10pp | -0.9% | |||
Dr. Reddy's Laboratories. EBITDA margin, %
Dr. Reddy's Laboratories. EBITDA margin, changes, pp
Dr. Reddy's Laboratories (RDY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | 2026Q4 | LTM ? | |||
| EBITDA margin, % | ? | 29.7% | 28.8% | 27.6% | 22.4% | 8.04% | 22.1% | |
| Changes by years, y/y, % | +1pp | +0pp | -2pp | -7pp | -22pp | |||
| Changes by quarters, q/q, % | +1pp | -1pp | -1pp | -5pp | -14pp | |||
